On the 2nd of March 2020, Saudi Arabia confirmed its first case of the newly emerging strain of the coronavirus, known as coronavirus disease 2019 (COVID-19). Ever Since, the number of confirmed cases nationally started to increase. Saudi officials took several proactive precautionary measures and actions. In light of the emerging outbreak, all healthcare professionals, including pharmacists, came to function at more than their maximum capacity. The Saudi Society of Clinical Pharmacy (SSCP) understands the magnitude of impact pharmacists can play during this outbreak. For this reason, the SSCP aims to provide guidance regarding the pharmacist's roles and responsibilities based on existing scientific knowledge during this outbreak.
In December 2019, an alarming epidemic of unexplained etiology pneumonia occurred in Wuhan City, Hubei Province, China. The World Health Organisation (WHO) described a novel coronavirus as the causative agent, which was subsequently named COVID-19. Ever Since the outbreak started to spread from one country to the other. Due to the alarming number of infected cases around the world. The WHO made the assessment that COVID-19 can be characterized as a pandemic on 11 March 2020. Many countries started to take proactive or reactive actions to prevent the spread of the virus. Like many of the other countries, SA began to to take proactive measures and actions to limit the spread of the outbreak. For instance, on 27 February 2020, Saudi Arabia declared that it will immediately suspend entry for individuals wishing to conduct the Umrah in Mecca. Moreover, On 8 March, the Saudi Ministry of Education announced the closing of the schools and universities. On 20 March, the Ministry of the Interior halted domestic airlines, ships, busses, and taxis for 14 days. Many other precautionary measures were taken by the Saudi officials to stop the spread of the COVID-19. All sectors have been impacted by this outbreak, including the health sectors. Historical evidence showed that the skills and knowledge pharmacists have could allow them to play a major role during natural disasters and outbreaks
These recommendations aim to provide pharmacists with guidance regarding the pharmacist's roles and responsibilities based on existing scientific knowledge during this outbreak.
Executive Summary of the Recommendation (1-2 Paragraphs from 200 to 500 words)
Recommendation 1: We urge pharmacists to take a proactive role in educating others regarding infection prevention measures.
During the outbreak , it is crucial that all pharmacists should ensure the adherence to recommended antimicrobial therapy practices. Previous evidence shows that pharmacists can play a major role in correcting the prescribing misbehaviours and educate the healthcare providers regarding the wise use of antibiotics and infection measures.
Recommendation 2: We urge pharmacists to provide authentic and evidence-based guidance to patients and healthcare providers. (Hisham)
Previous  evidence shows that pharmacists can take a proactive role in educating the public and encourage all pharmacists to take part in educating the public and healthcare providers. During the outbreak, we encourage all hospital and community pharmacists to serve as valuable information resource for patients and other healthcare providers.
Recommendation 3: We urge pharmacists and pharmacy professionals to create institutional protocols and strategies for symptom management for patients with minor viral illnesses. (Dr.Ahmed)
Recommendation 4: We urge pharmacists to direct people to reliable resources. (Dr.Ahmed)
Recommendation 5: We urge pharmacists to take an integral part in participating in institutional and national guidelines dealing with the COVID-19 outbreak, especially when it comes to the pharmacotherapy part. (Dr.Ahmed)